VRD

Thatcham Research Selects LexisNexis Risk Solutions to Deliver Transformational Automotive Risk Intelligence to the U.K. Insurance Industry

Retrieved on: 
Tuesday, March 5, 2024

LONDON, March 5, 2024 /PRNewswire/ -- In a major development for the U.K. insurance industry, LexisNexis® Risk Solutions, the data, advanced analytics and technology provider, has secured an exclusive strategic relationship with Thatcham Research, in the first contract of its kind with the insurer-funded automotive risk intelligence company. The strategic relationship is set to transform the accessibility, consistency and analytical power of Thatcham Vehicle Risk Data (VRD)i which is used to assign an industry-standard ABI Code and Group Rating score to vehicles. The VRD is integral to how insurers assess and rate risk for all wheels-based insurance products.

Key Points: 
  • The news comes as the Association of British Insurers, in close collaboration with Thatcham Research, has released its motor insurance affordability roadmapii.
  • LexisNexis Risk Solutions will become the sole distributor of Thatcham VRD to the U.K. and ROI insurance market.
  • This strategy makes LexisNexis Risk Solutions well-placed to unlock the potential in the Thatcham VRD product, creating transformational insights for motor insurance providers.
  • The combination of Thatcham Research and LexisNexis Risk Solutions assets and intelligence is compelling, providing an exciting roadmap for new services and insights that will improve the overall motor insurance customer experience."

EyeJets to Unveil Patented VRD and Eye-Tracking Technology at AWE Vienna

Retrieved on: 
Tuesday, October 17, 2023

TEL AVIV, Israel, Oct. 17, 2023 /PRNewswire/ -- EyeJets, the startup Israeli smartglasses technology company, is thrilled to announce its debut demonstration of their patented retinal eye-tracking feature (RET) combined with Virtual Retinal Display (VRD) technology on October 24-25, at AWE Vienna.

Key Points: 
  • The innovative smartglasses technology developed by EyeJets represents a revolutionary leap in the world of AR.
  • By combining VRD and eye-tracking, EyeJets has created an exceptionally compact, lightweight eyewear solution that's comfortable and safe for all-day use.
  • Attendees of AWE Vienna can experience this game-changing technology firsthand at EyeJets' booth #258, located in AWE's main expo hall.
  • Edu Strul, CEO of EyeJets and Co-founder, explained, "At EyeJets, we are dedicated to pushing the boundaries of smart eyewear technology.

  Valneva Announces Successful Outcome of its AGM and the Appointment of Pfizer’s Former Vaccine R&D Head to its Supervisory Board

Retrieved on: 
Wednesday, June 21, 2023

Dr Kathrin U Jansen, Ph.D., a German national with over 30 years of vaccine R&D experience, was appointed to Valneva’s Supervisory Board for a three-year term.

Key Points: 
  • Dr Kathrin U Jansen, Ph.D., a German national with over 30 years of vaccine R&D experience, was appointed to Valneva’s Supervisory Board for a three-year term.
  • Prior to Wyeth, Dr. Jansen spent 12 years at Merck Research Laboratories supporting several vaccine efforts and leading the R&D activities of Gardasil®, the world’s first cervical cancer vaccine.
  • Additionally, the term of office of Supervisory Board members Ms. Johanna W. Pattenier and Ms. Sharon E. Tetlow was renewed until June 2026.
  • The AGM’s voting results will be made available in the “ Investors & Media ” section of Valneva’s corporate website in the coming days.

Introducing KODO Assets – Participate in the Real Estate market through Tokenization

Retrieved on: 
Thursday, November 17, 2022

This in turn provides those interested in dipping their toes into the market a platform that mitigates some key problems discovered in the traditional real estate market.

Key Points: 
  • This in turn provides those interested in dipping their toes into the market a platform that mitigates some key problems discovered in the traditional real estate market.
  • Through the capabilities of tokenization, KODO is able to mend the gaps that haunt the real estate sector and bring new light to those that wish to participate in this hard-to-reach industry.
  • Kodo Assets was born because of the belief that tokenization is the best way to solve the biggest problems in the real estate market, such as low liquidity, high barriers to entry, high transaction costs and bureaucracy that keep many investors from getting into the real estate market.
  • The two form the backbone of KODO with their extensive entrepreneurial experiences, promising a sturdy solution for the future of tokenized real estate.

ARCCAPTAIN Releases the Best 200Amps MIG Welder MIG200 in 2022

Retrieved on: 
Thursday, November 3, 2022

NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) -- According to official news, the brand-new electric welding machine brand ARCCAPTAIN has released the new 200Amps mig welder MIG200, which is known as the best mig welder on the market, in terms of quality and function.

Key Points: 
  • NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) -- According to official news, the brand-new electric welding machine brand ARCCAPTAIN has released the new 200Amps mig welder MIG200, which is known as the best mig welder on the market, in terms of quality and function.
  • ARCCAPTAIN MIG200 Product Development Engineer Jacob Lee said: "The ARCCAPTAIN MIG200 multifunction welder is a universal-class professional welder that is very simple to use.
  • Among the same price machines, the ARCCAPTAIN MIG200 could be the best mig welder on the market in 2022 in terms of quality and functionality.
  • The ARCCAPTAIN MIG200 machine is currently available on the official website and Amazon store.

Screenless Display Market to Reach USD 14.9 Billion by 2030 Growing at a CAGR of 23% | Valuates Reports

Retrieved on: 
Thursday, July 21, 2022

The global Metaverse market size is projected to reach USD 28 Billion by 2028, from 510 USD Million in 2022, at a CAGR of 95% during 2022-2028.

Key Points: 
  • The global Metaverse market size is projected to reach USD 28 Billion by 2028, from 510 USD Million in 2022, at a CAGR of 95% during 2022-2028.
  • The global artificial intelligence market size was valued at USD 65.48 Billion in 2020, and is projected to reach USD 1,581.70 Billion by 2030, growing at a CAGR of 38.0% from 2021 to 2030.
  • The global Cloud Gaming market size is projected to reach USD 1169.1 Million by 2027, from USD 133.7 Million in 2020, at a CAGR of 35.4% during 2021-2027.
  • The global Mixed Reality market size is projected to reach USD 2482.9 Million by 2028, from USD 331.4 Million in 2021, at a CAGR of 28.7% during 2022-2028.

Screenless Display Market to Reach USD 14.9 Billion by 2030 Growing at a CAGR of 23% | Valuates Reports

Retrieved on: 
Thursday, July 21, 2022

The global Metaverse market size is projected to reach USD 28 Billion by 2028, from 510 USD Million in 2022, at a CAGR of 95% during 2022-2028.

Key Points: 
  • The global Metaverse market size is projected to reach USD 28 Billion by 2028, from 510 USD Million in 2022, at a CAGR of 95% during 2022-2028.
  • The global artificial intelligence market size was valued at USD 65.48 Billion in 2020, and is projected to reach USD 1,581.70 Billion by 2030, growing at a CAGR of 38.0% from 2021 to 2030.
  • The global Cloud Gaming market size is projected to reach USD 1169.1 Million by 2027, from USD 133.7 Million in 2020, at a CAGR of 35.4% during 2021-2027.
  • The global Mixed Reality market size is projected to reach USD 2482.9 Million by 2028, from USD 331.4 Million in 2021, at a CAGR of 28.7% during 2022-2028.

Reformulated Diesel Fuel Drops Emissions Below that of Hybrid Electric Vehicles

Retrieved on: 
Friday, July 15, 2022

LAS VEGAS, July 15, 2022 /PRNewswire/ -- Vegas Renewable Diesel Inc. (VRD) announces the successful development and testing of a near non-polluting, reformulated diesel fuel that is fully drop-in compatible with diesel #2 (ASTM D975).

Key Points: 
  • LAS VEGAS, July 15, 2022 /PRNewswire/ -- Vegas Renewable Diesel Inc. (VRD) announces the successful development and testing of a near non-polluting, reformulated diesel fuel that is fully drop-in compatible with diesel #2 (ASTM D975).
  • These problems are caused when diesel engines produce soot as a result of incomplete fuel combustion.
  • VRD has reformulated the old, soot-laden diesel fuel that has gone unimproved for over 150 years.
  • Opacity is less than a hybrid electric vehicle
    Burning our top tier UC2 diesel will extend the life of your engines.

Apex, Nevada Site Acquired for Largest Western US Renewable Diesel Refinery

Retrieved on: 
Monday, June 13, 2022

LAS VEGAS, June 13, 2022 /PRNewswire/ -- Vegas Renewable Diesel Inc. (VRD) announces acquisition of a prime site near Las Vegas for the largest renewable diesel refinery to be built in the Western United States.

Key Points: 
  • LAS VEGAS, June 13, 2022 /PRNewswire/ -- Vegas Renewable Diesel Inc. (VRD) announces acquisition of a prime site near Las Vegas for the largest renewable diesel refinery to be built in the Western United States.
  • Capacity is targeted at 100 million gallons per month of renewable diesel.
  • VRD has spent 2021 and the first half of 2022 preparing its renewable diesel refinery in Las Vegas with a production capacity of 1 million gallons per month.
  • To learn more about VRD, go to:
    View original content to download multimedia: https://www.prnewswire.com/news-releases/apex-nevada-site-acquired-for-l...
    SOURCE Vegas Renewable Diesel Inc.

New Clinical and Real-World Data Support Use of DARZALEX®▼ (daratumumab) in Patients with Newly Diagnosed Multiple Myeloma

Retrieved on: 
Saturday, December 11, 2021

The clinical data presented at ASH support daratumumab as a foundational therapy for patients with newly diagnosed multiple myeloma in transplant-ineligible populations, said Imran Khan, M.D., Ph.D., U.S. Vice President, Medical Affairs, Hematology, Janssen Scientific Affairs, LLC.

Key Points: 
  • The clinical data presented at ASH support daratumumab as a foundational therapy for patients with newly diagnosed multiple myeloma in transplant-ineligible populations, said Imran Khan, M.D., Ph.D., U.S. Vice President, Medical Affairs, Hematology, Janssen Scientific Affairs, LLC.
  • Real-world evidence about efficacy, safety and adherence is becoming increasingly important for clinicians in optimising treatment approaches for patients with multiple myeloma.
  • Janssen is committed to exploring the potential of daratumumab for patients with multiple myeloma across the spectrum of the disease.
  • Real-World Patient Characteristics and Treatment Outcomes Among Newly Diagnosed Multiple Myeloma Patients Initiating Daratumumab, Lenalidomide, and Dexamethasone As First-Line Therapy.